3rd Quarter - Report

GOVERNMENT COUNSEL, LLC for HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS)

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

S.2209/H.R.4128-Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, and H.R. 7667, Food and Drug Amendments of 2022, relating to the establishment of a regulatory framework for laboratory developed tests.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7667 (117th), S. 4348 (117th), S. 2209 (117th), H.R. 4128 (117th)

Health Issues HCR

H.R. 8188/S.4449-Saving Access to Laboratory Services Act (SALSA).

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 8188 (117th), S. 4449 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.